1. Home
  2. GMEX vs SHPH Comparison

GMEX vs SHPH Comparison

Compare GMEX & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GMEX

GMEX ROBOTICS CORPORATION Class A Ordinary Shares

N/A

Current Price

$0.78

Market Cap

1.7M

ML Signal

N/A

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

HOLD

Current Price

$3.46

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMEX
SHPH
Founded
2005
2012
Country
Australia
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
2.1M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
GMEX
SHPH
Price
$0.78
$3.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
286.2K
32.5K
Earning Date
04-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.38
52 Week High
$4.57
$6.15

Technical Indicators

Market Signals
Indicator
GMEX
SHPH
Relative Strength Index (RSI) 33.12 48.63
Support Level $0.45 $3.29
Resistance Level $1.28 $4.64
Average True Range (ATR) 0.09 0.31
MACD -0.02 -0.07
Stochastic Oscillator 4.42 24.96

Price Performance

Historical Comparison
GMEX
SHPH

About GMEX GMEX ROBOTICS CORPORATION Class A Ordinary Shares

GMEX Robotics Corp is engaged in the design and deployment of AI-powered robotics and intelligent consumer technologies. The group operates in three business areas: Consumer and Commercial Robotics: Developing intuitive and interactive robots designed to assist with daily tasks, provide smart home integration, and offer new levels of convenience and connectivity to boost productivity; AI-Driven Hardware: Embedding artificial intelligence into physical products to create self-learning and adaptive user experiences; and Innovation & Ecosystem: Building a robust ecosystem of robotic products that communicate and evolve, powered by proprietary AI algorithms.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.

Share on Social Networks: